2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow GVHD: new trials by email Literature Review of GVHD trials Research Report on GVHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis PTCY - GVHD | Phase 3 | Unknown | Shanghai Jiao Tong University School of Medicine | 138 | 2023-10-01 | 2023-08-21 |
| Outcomes of Patients After Allo-HSCT With Decitabine and NAC decitabine, Acetylcysteine, Semustine - Engraft Failure, Relapse | Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 100 | 2021-07-01 | 2021-06-30 |
Graft vs Host Disease (1) · Recurrence (1)
Disease Attributes (1) · Immune System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Acetylcysteine (1) · Antilymphocyte Serum (1) · Busulfan (1) · Cyclophosphamide (1) · Cyclosporine (1) · Cytarabine (1) · Decitabine (1) · Mycophenolic Acid (1) · Semustine (1) · thymoglobulin (1)
Shanghai Jiao Tong University School of Medicine (1) · The First Affiliated Hospital of Soochow University (1)
China (1)
Yue Han, Prof. (1)